original ) (raw )Do the Cardiovascular Effects of Angiotensin-Converting Enzyme (ACE) I Involve ACE-Independent Mechanisms? New Insights from Proline-Rich Peptides of Bothrops jararaca
Danielle Ianzer , G. Etelvino
Journal of Pharmacology and Experimental Therapeutics, 2007
View PDFchevron_right
ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
Sergio Lavandero
Therapeutic advances in cardiovascular disease, 2015
View PDFchevron_right
Shedding the load of hypertension: the proteolytic processing of angiotensin-converting enzyme
Kerry Gordon
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2012
View PDFchevron_right
Rediscovering ACE: novel insights into the many roles of the angiotensin-converting enzyme
Sebastien Fuchs
Journal of Molecular Medicine, 2013
View PDFchevron_right
Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors
Keizo Kanasaki
Fibrogenesis & Tissue Repair, 2011
View PDFchevron_right
Bioavailability of angiotensin I converting enzyme inhibitory peptides
Vanessa Vermeirssen
British Journal of Nutrition, 2004
View PDFchevron_right
A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme
Sebastien Fuchs
Pharmacological Reviews, 2012
View PDFchevron_right
Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE)
Sebastien Fuchs
Current Opinion in Pharmacology, 2011
View PDFchevron_right
The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data
John Deanfield
The American Journal of Cardiology, 2001
View PDFchevron_right
A Novel Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9
Keith Robison
Circulation Research, 2000
View PDFchevron_right
Structural characteristics and antihypertensive effects of angiotensin-I-converting enzyme inhibitory peptides in the renin-angiotensin and kallikrein kinin systems-ISI/Scopus
Sivananthan Manoharan
View PDFchevron_right
Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1–7) in regulation of cardiovascular function
Carlos Ferrario
American Journal of Physiology-Heart and Circulatory Physiology, 2005
View PDFchevron_right
Structural Characteristics and Antihypertensive Effects of Angiotensin-I-Converting Enzyme Inhibitory Peptides in the Renin-Angiotensin and Kallikrein Kinin Systems
Adawiyah Shuib
African journal of traditional, complementary, and alternative medicines : AJTCAM, 2017
View PDFchevron_right
Isolation of Acein-2, a novel angiotensin-I-converting enzyme inhibitory peptide derived from a tryptic hydrolysate of human plasma
和哉 中込
FEBS Letters, 2000
View PDFchevron_right
Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death
Samuel Dudley
The American Journal of Pathology, 2004
View PDFchevron_right
Angiotensin-converting enzyme inhibition to enhance vascular health--clinical and research models
George Bakris
American journal of hypertension, 2001
View PDFchevron_right
Nontraditional Roles of Angiotensin-Converting Enzyme
Sebastien Fuchs
Hypertension, 2012
View PDFchevron_right
In Vitro and Ex Vivo Studies on Angiotensin-I Converting Enzyme (Ace) Inhibitory Activity of Short Synthetic Peptides
Ivanka Stoineva
Farmacia, 2021
View PDFchevron_right
Renal and Metabolic Clearance of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (AcSDKP) During Angiotensin-Converting Enzyme Inhibition in Humans
Joanna Bakala
Hypertension, 1999
View PDFchevron_right
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent
Daniel Batlle
Hypertension, 2019
View PDFchevron_right
Angiotensin‐converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
Louise Burrell
Experimental Physiology, 2008
View PDFchevron_right
Acein-1, a novel angiotensin-I-converting enzyme inhibitory peptide isolated from tryptic hydrolysate of human plasma
和哉 中込
FEBS Letters, 1998
View PDFchevron_right
ACE2 of the heart: From angiotensin I to angiotensin (1–7)
Aviva Lazarovich
Cardiovascular Research, 2007
View PDFchevron_right
New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition
Andrea Daragó
PLoS ONE, 2014
View PDFchevron_right
Vascular Angiotensin-Converting Enzyme 2: Lord of the Ring?
Daniel Batlle
Circulation Research, 2010
View PDFchevron_right
Role of the N-terminal Catalytic Domain of Angiotensin-converting Enzyme Investigated by Targeted Inactivation in Mice
Sebastien Fuchs
Journal of Biological Chemistry, 2004
View PDFchevron_right